Cara Therapeutics's change in inventory for the quarter that ended in Dec. 2023 was $0.45 Mil. It means Cara Therapeutics's inventory
declined by $0.45 Mil
from Sep. 2023 to Dec. 2023 .
Cara Therapeutics's change in inventory for the fiscal year that ended in Dec. 2023 was $-0.44 Mil. It means Cara Therapeutics's inventory
increased by $0.44 Mil
from Dec. 2022 to Dec. 2023 .
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Cara Therapeutics's Days Inventory for the quarter that ended in Dec. 2023 was 456.78.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Cara Therapeutics's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.20.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cara Therapeutics's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 1.01.
Cara Therapeutics Change In Inventory Historical Data
The historical data trend for Cara Therapeutics's Change In Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.
Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.44 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cara Therapeutics (NAS:CARA) Change In Inventory Explanation
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Cara Therapeutics's Days Inventory for the quarter that ended in is calculated as:
3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cara Therapeutics's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cara Therapeutics Change In Inventory Related Terms
Thank you for viewing the detailed overview of Cara Therapeutics's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Cara Therapeutics (Cara Therapeutics) Business Description
Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CARA has been successfully added to your 